Application

ANDOVER RESEARCH EYE INSTITUTE

Ora, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 98122254
Filing Date: 08/08/2023

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 98122254
MARK INFORMATION
*MARK ANDOVER RESEARCH EYE INSTITUTE
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ANDOVER RESEARCH EYE INSTITUTE
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Ora, Inc.
*MAILING ADDRESS 300 Brickstone Square
*CITY Andover
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
01810
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Massachusetts
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 035 
*IDENTIFICATION business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes; business development services; advertising consulting services; public relations
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Michael R. Rizzo
ATTORNEY DOCKET NUMBER 1500.405.33
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Saunders & Silverstein LLP
INTERNAL ADDRESS Suite 224
STREET 14 Cedar Street
CITY Amesbury
STATE Massachusetts
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 01913
EMAIL ADDRESS mrizzo@sandsip.com
OTHER APPOINTED ATTORNEY Each of the attorneys of Saunders & Silverstein LLP
CORRESPONDENCE INFORMATION
NAME Michael R. Rizzo
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE mrizzo@sandsip.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) trademarks@sandsip.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 700
*TOTAL FEES PAID 700
SIGNATURE INFORMATION
SIGNATURE NOT PROVIDED
SIGNATORY'S NAME NOT PROVIDED
SIGNATORY'S POSITION NOT PROVIDED
DATE SIGNED NOT PROVIDED



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 98122254
Filing Date: 08/08/2023

To the Commissioner for Trademarks:

MARK: ANDOVER RESEARCH EYE INSTITUTE (Standard Characters, see mark)
The literal element of the mark consists of ANDOVER RESEARCH EYE INSTITUTE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Ora, Inc., a corporation of Massachusetts, having an address of
      300 Brickstone Square
      Andover, Massachusetts 01810
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 035:  business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes; business development services; advertising consulting services; public relations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Michael R. Rizzo. Other appointed attorneys are Each of the attorneys of Saunders & Silverstein LLP. Michael R. Rizzo of Saunders & Silverstein LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Suite 224
      14 Cedar Street
      Amesbury, Massachusetts 01913
      United States
      mrizzo@sandsip.com
The docket/reference number is 1500.405.33.
Michael R. Rizzo submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Michael R. Rizzo
       PRIMARY EMAIL FOR CORRESPONDENCE: mrizzo@sandsip.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@sandsip.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 98122254
Payment Accounting Date: 08/08/2023

Serial Number: 98122254
Internet Transmission Date: Tue Aug 08 14:57:57 ET 2023
TEAS Stamp: USPTO/BAS-XXXX:XXX:XXXX:XXXX:XXXX:XXXX:X
XXX:XXXX-20230808145759176321-98122254-8
60f737a91615b35c795dfc43b51496b1be891198
df748a8801b7e659ef853de9-CC-57576634-202
30808145315804260

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed